Andrew David Levin - Aug 9, 2021 Form 3 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
Director
Signature
/s/ Alan Hambelton, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
3
Date filed
8/9/2021, 06:16 PM
Next filing
Jun 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELYM No securities are beneficially owned. 0 Aug 9, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.